Unilever Q3 Sales Rise, Backs FY21 Margin View; Declares Dividend - Quick Facts

Consumer goods giant Unilever plc. (UN,ULVR.L,UL) reported Thursday that its third-quarter turnover grew 4 percent to 13.45 billion euros from last year's 12.93 billion euros.

Underlying sales growth was 2.5 percent, with 4.1 percent increase in price, while volume dropped 1.5 percent.

Beauty & Personal Care sales were 5.69 billion euros. Underlying sales grew 2.6 percent, with 3.9 percent from price and negative 1.3 percent from volume.

Home Care underlying sales grew 1.4 percent. Foods & Refreshment underlying sales grew 3 percent.

Further, the Board has declared a quarterly interim dividend of 0.3598 pounds per Unilever PLC ordinary share or 0.4268 euro per Unilever PLC ordinary share.

Looking ahead, the company said it continues to expect to deliver in line with margin guidance of around flat for the full year.

Chief Executive Officer Alan Jope said, "The combination of our strategic choices and focus on operational excellence continue to drive competitive growth. Underlying sales growth is now at 4.4 percent for the year to date and we are confident that we will be well within our multi-year framework of 3-5 percent for the full year."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Privately-held biotechnology company On Target Laboratories, Inc. announce that the U.S. Food and Drug Administration or FDA, has approved Cytalux (pafolacianine) for adult patients with ovarian cancer as an adjunct for intraoperative identification of malignant lesions. Cytalux is the first targeted fluorescent imaging agent that illuminates ovarian cancer intraoperatively. The Federal Trade Commission or FTC has ordered Walmart, Amazon, Kroger and certain other large wholesalers and suppliers to provide information to help it study causes of supply chain disruptions. The agency has launched an inquiry to find the reasons for empty shelves and exorbitant prices. Along with Walmart, Amazon.com, and Kroger, the order has been sent to C&S Wholesale Grocers, Associated.. Covid vaccine maker Moderna Inc.'s Chief Executive Stéphane Bancel has predicted that existing COVID-19 vaccines will be much less effective against Omicron than earlier strains, according to the Financial Times.
Follow RTT